Dexamethasone in Hospitalized Patients with Covid-19

Cited by (1,035)

Items 301–400 of 1,035

1. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)
   Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker, Lindsey Robert Baden, Vincent Chi‐Chung Cheng, Kathryn M. Edwards, Jason C Gallagher, Rajesh Tim Gandhi, William J. Muller, Mari Nakamura et al. · 2022 · Clinical Infectious Diseases
2. Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19.
   Kory, Pierre, Meduri, Gianfranco Umberto, Varon, Joseph, Iglesias, Jose, Marik, Paul E. · 2021 · American Journal of Therapeutics
3. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future
   Olayinka O. Ogunleye, Debashis Basu, Debjani Mueller, Jacqueline Sneddon, Ronald Andrew Seaton, Adesola F. Yinka-Ogunleye, Joshua Wamboga, Nenad Miljković, Julius Chacha Mwita, Godfrey Mutashambara Rwegerera et al. · 2020 · Frontiers in Pharmacology
4. Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study
   Bruce McClure Biccard, PD Gopalan, Malcolm Miller, William Lance Michell, David Alexander Thomson, Adesoji Oludotun Ademuyiwa, Ernest A. Aniteye, Greg Calligaro, Maman Sani Chaibou, Hailu Tamiru Dhufera et al. · 2021 · The Lancet
5. Genetically engineered cell membrane–coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs
   Joon Ho Park, Yao Jiang, Jiarong Zhou, Hua Gong, Animesh Mohapatra, Jiyoung Heo, Weiwei Gao, Ronnie H. Fang, Liangfang Zhang · 2021 · Science Advances
6. Systemic corticosteroids for the treatment of COVID-19
   Carina Wagner, Mirko Griesel, Agata Mikołajewska, Anika Mueller, Monika Nothacker, Karoline Kley, Maria‐Inti Metzendorf, Anna-Lena Fischer, Marco Kopp, Miriam Songa Stegemann et al. · 2021 · Cochrane Database of Systematic Reviews
7. JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality
   Justin Stebbing, Ginés Sánchez Nievas, Marco Falcone, Sonia C. Youhanna, Peter J. Richardson, Silvia Ottaviani, Joanne X. Shen, Christian Sommerauer, Giusy Tiseo, Lorenzo Ghiadoni et al. · 2020 · Science Advances
8. Overview of SARS-CoV-2 infection in adults living with HIV
   Juan Ambrosioni, José Luís Blanco, Juliana Reyes‐Urueña, Mary‐Ann Davies, Omar Gustavo Sued, María Ángeles Marcos, Estebán Martínez, Silvia Bertagnolio, José Alcamı́, José Ma Miró et al. · 2021 · The Lancet HIV
9. Burden and characteristics of COVID-19 in the United States during 2020
   Pei, Sen, Yamana, Teresa K., Kandula, Sasikiran, Galanti, Marta, Shaman, Jeffrey · 2021 · Nature
10. Drug repurposing for COVID-19 via knowledge graph completion
    Rui Zhang, Dimitar Hristovski, Dalton Schutte, Andrej Kastrin, Marcelo Fiszman B, Halil Kilicoglu B · 2021 · Journal of Biomedical Informatics
11. Community-Acquired Pneumonia
    Valerie M. Vaughn, Robert P. Dickson, Jennifer K. Horowitz, Scott A. Flanders · 2024 · JAMA
12. Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be
    Giuseppina Mariano, Rebecca J. Farthing, Shamar L. M. Lale-Farjat, Julien R. C. Bergeron · 2020 · Frontiers in Molecular Biosciences
13. NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
    Ralf Kircheis, Emanuel Haasbach, Daniel Lueftenegger, Willm T. Heyken, Matthias Ocker, Oliver Planz · 2020 · Frontiers in Immunology
14. IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression
    Sujan Kumar Dhar, K. Vishnupriyan, Sharat Damodar, Shashi Ashok Gujar, Manjula Das · 2021 · Heliyon
15. Sino-orbital mucormycosis in a COVID-19 patient
    Aastha Maini, Gaurav Tomar, Deepak Khanna, Yogesh Kini, Hardik Mehta, V. Bhagyasree · 2021 · International Journal of Surgery Case Reports
16. Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay
    Chunlong Ma, Michael Dominic Sacco, Zilei Xia, George Lambrinidis, Julia Alma Townsend, Yanmei Hu, Xiangzhi Meng, Tommy Szeto, Mandy Ba, Xiujun Zhang et al. · 2021 · ACS Central Science
17. Deep insight into cytokine storm: from pathogenesis to treatment
    Jiali Nie, Ling Zhou, Weiwei Tian, Xiansheng Liu, Liping Yang, Xingcheng Yang, Yicheng Zhang, Shuang Wei, Dao Wen Wang, Jia Wei · 2025 · Signal Transduction and Targeted Therapy
18. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia
    Miguel Alejandro Pinzón, Santiago Ortiz, Héctor Holguín, Juan Felipe Betancur, Doris Cardona Arango, Henry Laniado, Carolina Arias Arias, Bernardo Muñoz, Julián Quiceno, Daniel Jaramillo et al. · 2021 · PLoS ONE
19. Dexamethasone in the management of covid -19
    Raymond M. Johnson, Joseph Michael Vinetz · 2020 · BMJ
20. COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis
    Kyung Mok Sohn, Sung‐Gwon Lee, Hyeon Ji Kim, Shinhye Cheon, Hyeongseok Jeong, Joo-Yeon Lee, In Soo Kim, Prashanta Silwal, Young Jae Kim, Seungwha Paik et al. · 2020 · Journal of Korean Medical Science
21. Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study
    Rishi K Gupta, Michael Marks, Thomas H. A. Samuels, Akish Luintel, Tommy Rampling, Humayra Chowdhury, Matteo Quartagno, Arjun Nair, Marc C.I. Lipman, Ibrahim Abubakar et al. · 2020 · European Respiratory Journal
22. COVID-19 and myocarditis: a systematic review and overview of current challenges
    Teresa Castiello, Georgios A. Georgiopoulos, Gherardo Finocchiaro, Monaco Claudia, Andrea Gianatti, Dimitrios Delialis, Alberto Aimo, Sanjay Kumar Prasad · 2021 · Heart Failure Reviews
23. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
    FAI 2 R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors · 2020 · Annals of the Rheumatic Diseases
24. Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19
    Alon, Ronen, Sportiello, Mike, Kozlovski, Stav, Kumar, Ashwin, Reilly, Emma C., Zarbock, Alexander, Garbi, Natalio, Topham, David J. · 2021 · Nature Reviews Immunology
25. Sex differences in COVID-19: the role of androgens in disease severity and progression
    Mohamed S. Mohamed, Thiago C. Moulin, Helgi B. Schiöth · 2020 · Endocrine
26. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
    Shuofeng Yuan, Runming Wang, Jasper Fuk‐Woo Chan, Jinxia Zhang, Tianfan Cheng, Kenn Ka‐Heng Chik, Zi‐Wei Ye, Suyu Wang, Andrew Chak-Yiu Lee, Lijian Jin et al. · 2020 · Nature Microbiology
27. Vitamin C—An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19
    Patrick Holford, Anitra C. Carr, Thomas Harry Jovic, Stephen R Ali, Iain Stuart Whitaker, Paul Ellis Marik, Adrian D. Smith · 2020 · Nutrients
28. Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic
    Sobia Noreen, Irsah Maqbool, Asadullah Madni · 2021 · European Journal of Pharmacology
29. Corticosteroids in COVID-19 ARDS
    Hallie C. Prescott, Todd W. Rice · 2020 · JAMA
30. Updates on community acquired pneumonia management in the ICU
    GIRISH BALACHANDRAN NAIR, Michael S. Niederman · 2020 · Pharmacology & Therapeutics
31. Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic
    John P. A. Ioannidis · 2020 · European Journal of Clinical Investigation
32. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China
    Zhilin Zeng, Haijing Yu, Huilong Chen, Weipeng Qi, Liang Chen, Guang Chen, Weiming Yan, Tao Chen, Qin Ning, Meifang Han et al. · 2020 · Critical Care
33. Methodological quality of COVID-19 clinical research
    Jung, Richard G., Di Santo, Pietro, Clifford, Cole, Prosperi-Porta, Graeme, Skanes, Stephanie, Hung, Annie, Parlow, Simon, Visintini, Sarah, Ramirez, F. Daniel, Simard, Trevor et al. · 2021 · Nature Communications
34. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases
    Meng–Huang Wu, Yaobing Chen, Han Xia, Changli Wang, Chin Yee Tan, Xunhui Cai, Yufeng Liu, Fenghu Ji, Xiong Peng, Ran Liu et al. · 2020 · Proceedings of the National Academy of Sciences
35. One year update on the COVID-19 pandemic: Where are we now?
    Sanjay Kumar Mishra, Timir Tripathi · 2020 · Acta Tropica
36. Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
    Michael A. Thompson, Jeffrey P. Henderson, Pankil Shah, Samuel M. Rubinstein, Michael J. Joyner, Toni K. Choueiri, Daniel Blake Flora, Elizabeth A. Griffiths, Anthony P. Gulati, Clara Hwang et al. · 2021 · JAMA Oncology
37. Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial
    E Wesley Ely, Athimalaipet Vaidyanathan Ramanan, Cynthia E Kartman, Stephanie de Bono, Ran Liao, Maria Lucia B Piruzeli, Jason D Goldman, José Francisco Kerr Saraiva, Sujatro Chakladar, Vincent C. Marconi et al. · 2022 · The Lancet Respiratory Medicine
38. Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation
    Sally J. Singh, Molly M Baldwin, Enya Daynes, Rachael A Evans, Neil J. Greening, Gisli R. Jenkins, Nazir Lone, Hamish J. C. McAuley, Puja Mehta, Joseph V. Newman et al. · 2023 · The Lancet Respiratory Medicine
39. The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19
    Lauren A. Callender, Michelle Curran, Stephanie M. Bates, Maelle Mairesse, Julia Weigandt, Catherine Jean Betts · 2020 · Frontiers in Immunology
40. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease
    Bavithra Vijayakumar, Karim Boustani, Patricia P. Ogger, Artemis Papadaki, James Tonkin, Christopher Michael Orton, Poonam Ghai, Kornelija Suveizdytė, Richard J. Hewitt, Sujal R. Desai et al. · 2022 · Immunity
41. Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes
    Byung‐Chul Lee, Insung Kang, Kyung–Rok Yu · 2021 · Journal of Clinical Medicine
42. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
    Wesley H. Self, Uriel Sandkovsky, Cavan S. Reilly, David M. Vock, Robert L. Gottlieb, Michael Mack, Kevin Golden, Emma Dishner, Andrew Vekstein, Emily R. Ko et al. · 2021 · The Lancet Infectious Diseases
43. COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
    Renuka Raman, Krishna J. Patel, Kishu Ranjan · 2021 · Biomolecules
44. Deep learning for drug repurposing: Methods, databases, and applications
    Xiaoqin Pan, Xuan Lin, Dongsheng Cao, Xiangxiang Zeng, Philip S. Yu, Lifang He, Ruth Nussinov, Feixiong Cheng · 2022 · Wiley Interdisciplinary Reviews Computational Molecular Science
45. COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
    Rebecca Grainger, Alfred H.J. Kim, Richard P. Conway, Jinoos Yazdany, Philip Cameron Robinson · 2022 · Nature Reviews Rheumatology
46. Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients
    Thieme, Constantin J., Anft, Moritz, Paniskaki, Krystallenia, Blazquez-Navarro, Arturo, Doevelaar, Adrian, Seibert, Felix S., Hoelzer, Bodo, Konik, Margarethe Justine, Berger, Marc Moritz, Brenner, Thorsten et al. · 2020 · Cell Reports Medicine
47. Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU
    Elinor Tan, Jialu Song, Adam M. Deane, Mark Philip Plummer · 2020 · CHEST Journal
48. Dexamethasone nanomedicines for COVID-19
    Twan Lammers, Alexandros Marios Sofias, Roy van der Meel, Raymond Michel Schiffelers, Gert Storm, Frank Tacke, Steffen Koschmieder, Tim H. Brümmendorf, Fabian M. Kiessling, Josbert M. Metselaar · 2020 · Nature Nanotechnology
49. Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease
    Katerina Pyrillou, Laura C. Burzynski, Murray C.H. Clarke · 2020 · Frontiers in Immunology
50. Drug combination therapy for emerging viral diseases
    Zeenat A. Shyr, Yu‐Shan Cheng, Donald C. Lo, Wei Zheng · 2021 · Drug Discovery Today
51. Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method
    Prashant Nasa, Élie Azoulay, Ashish Kumar Khanna, Ravi Jain, Sachin Gupta, Yash Javeri, Deven Juneja, Pradeep Rangappa, Krishnaswamy Sundararajan, Waleed A. Alhazzani et al. · 2021 · Critical Care
52. Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.
    Jesper Damsgaard Gunst, Nina Breinholt Stærke, Marie Høst Pahus, Lena Hagelskjær Kristensen, Jacob Bodilsen, Nicolai Lohse, Lars Dalgaard, Dorthe Brønnum, Ole Fröbert, Bo Langhoff Hønge et al. · 2021 · EClinicalMedicine
53. IL-13 is a driver of COVID-19 severity
    Alexandra N. Donlan, Tara E. Sutherland, Chelsea S. Marie, Saskia Preißner, Benjamin T. Bradley, Rebecca M. Carpenter, Jeffrey M. Sturek, Jennie Z. Ma, G. Brett Moreau, Jeffrey R. Donowitz et al. · 2021 · JCI Insight
54. Innate immunological pathways in COVID-19 pathogenesis
    Søren R. Paludan, Trine Hyrup Mogensen · 2022 · Science Immunology
55. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19
    Isabelle Bernard, Daniel Limonta, Lara K. Mahal, Tom C. Hobman · 2020 · Viruses
56. Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection
    Catherine Riou, Elsa Du Bruyn, Cari J. Stek, Remy Daroowala, Rene T. Goliath, Fatima Abrahams, Qonita Said-Hartley, Brian Allwood, Marvin Hsiao, Katalin Andrea Wilkinson et al. · 2021 · Journal of Clinical Investigation
57. Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19
    Azita H. Talasaz, Parham Sadeghipour, Hessam Kakavand, Maryam Aghakouchakzadeh, Elaheh Kordzadeh-Kermani, Benjamin W. Van Tassell, Azin Gheymati, Hamid Ariannejad, Seyed Hossein Hosseini, Sepehr Jamalkhani et al. · 2021 · Journal of the American College of Cardiology
58. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers
    Benjamin S. Abella, Eliana L. Jolkovsky, Barbara T. Biney, Julie E. Uspal, Matthew Craig Hyman, Ian Frank, Scott E. Hensley, Saar I. Gill, Dan T. Vogl, Ivan P. Maillard et al. · 2020 · JAMA Internal Medicine
59. COVID-19 and mucormycosis superinfection: the perfect storm
    Jaffar A. Al‐Tawfiq, Saad Alhumaid, Abeer N. Alshukairi, Mohamad-Hani A. Temsah, Mazin Adnan Barry, Abbas Saleh Al Mutair, Ali Ahmed Rabaan, Awad Al‐Omari, Raghavendra Tirupathi, Manaf AlQahtani et al. · 2021 · Infection
60. Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection
    Torben Kimhofer, Samantha Lodge, Luke Whiley, Nicola Gray, Ruey Leng Loo, Nathan G. Lawler, Philipp Nitschke, Sze-How Bong, DAVID L. MORRISON, Sofina Begum et al. · 2020 · Journal of Proteome Research
61. Structures of the glucocorticoid-bound adhesion receptor GPR97–Go complex
    Yu-Qi Ping, Chunyou Mao, Peng Xiao, Ru-Jia Zhao, Yi Jiang, Zhao Yang, Wentao An, Dandan Shen, Fan Yang, Huibing Zhang et al. · 2021 · Nature
62. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
    Vanessa Piechotta, Claire Iannizzi, Khai Li Chai, Sarah J Valk, Catherine Kimber, Elena Dorando, Ina Monsef, Erica M. Wood, Abigail Lamikanra, David J. Roberts et al. · 2021 · Cochrane Database of Systematic Reviews
63. A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19
    Zhou, Yadi, Hou, Yuan, Shen, Jiayu, Mehra, Reena, Kallianpur, Asha, Culver, Daniel A., Gack, Michaela U., Farha, Samar, Zein, Joe, Comhair, Suzy et al. · 2020 · PLoS Biology
64. Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis*
    Eleni Karakike, Evangelos J. Giamarellos‐Bourboulis, Miltiades Kyprianou, Carolin Fleischmann-Struzek, Mathias Wilhelm Pletz, Mihai Gheorghe Netea, Konrad Reinhart, Evdoxia Kyriazopoulou · 2021 · Critical Care Medicine
65. Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study
    Raquel Carbonell, Silvia Urgelés, Alejandro H. Rodríguez, María A. Bodí, Ignacio Martín‐Loeches, Jordi Solé‐Violán, Emili Dı́az, Josep Gómez, Sandra Trefler, Montserrat Vallverdú et al. · 2021 · The Lancet Regional Health - Europe
66. Acceptance of the coronavirus disease-2019 vaccine among medical students in Uganda
    Andrew Marvin Kanyike, Ronald Olum, Jonathan Kajjimu, Daniel Ojilong, Gabriel Madut Akech, Dianah Rhoda Nassozi, Drake Agira, Nicholas Kisaakye Wamala, Asaph Asiimwe, Dissan Matovu et al. · 2021 · Tropical Medicine and Health
67. Mucormycosis and COVID‐19: An epidemic within a pandemic in India
    Lav Selarka, Suktara Sharma, Dinesh Saini, Sanjay Kumar Sharma, Amit Batra, Vishal T. Waghmare, Pratibha Dileep, Sanket Patel, Monarch Shah, Tejas Parikh et al. · 2021 · Mycoses
68. A review of cytokine-based pathophysiology of Long COVID symptoms
    Russell N Low, Ryan J. Low, Athena Akrami · 2023 · Frontiers in Medicine
69. Worldwide Survey of COVID-19–Associated Arrhythmias
    Ellie J. Coromilas, Stephanie Kochav, Isaac L. Goldenthal, Angelo Biviano, Hasan Garan, Seth Goldbarg, Joon-Hyuk Kim, Ilhwan Yeo, Cynthia M. Tracy, Shant Ayanian et al. · 2021 · Circulation Arrhythmia and Electrophysiology
70. A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic
    Chris R. Triggle, Devendra Bansal, Hong Ding, Md. Mazharul Islam, Elmoubasher Farag, Hamad Abdel Hadi, Ali A. Sultan · 2021 · Frontiers in Immunology
71. Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study
    Djillali Annane, Nicholas Heming, Lamiae Grimaldi‐Bensouda, Véronique Frémeaux‐Bacchi, Marie Vigan, Anne-Laure Roux, Armance Marchal, Hugues Michelon, Martin Rottman, Pierre Moine · 2020 · EClinicalMedicine
72. Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic
    Tobias Boettler, Thomas Marjot, Philip Noel Newsome, Mario Umberto Mondelli, Mojca Matičič, Elisa Cordero, Rajiv Jalan, Richard Moreau, Markus Cornberg, Thomas Berg · 2020 · JHEP Reports
73. Azithromycin in viral infections
    Madeleine Oliver, Timothy Hinks · 2020 · Reviews in Medical Virology
74. Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes
    Edison Cano Cevallos, Xavier Fonseca Fuentes, Cristina Corsini Campioli, John Charles O’Horo, Omar Abu Saleh, Yewande Odeyemi, Hemang Yadav, Zelalem Temesgen · 2020 · CHEST Journal
75. Animal and translational models of SARS-CoV-2 infection and COVID-19
    Matt D. Johansen, Aaron Trent Irving, Xavier Montagutelli, Michelle D. Tate, Ina Rudloff, Marcel F. Nold, Nicole G. Hansbro, Richard Kim, Chantal Donovan, Gang Liu et al. · 2020 · Mucosal Immunology
76. Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
    Giulio Cavalli, Alessandro Larcher, Alessandro Tomelleri, Corrado Campochiaro, Emanuel Della‐Torre, Giacomo Davide De Luca, Nicola Farina, Nicola Boffini, Annalisa Ruggeri, Andrea Poli et al. · 2021 · The Lancet Rheumatology
77. High levels of eicosanoids and docosanoids in the lungs of intubated COVID‐19 patients
    Anne‐Sophie Archambault, Younes Zaid, Volatiana Rakotoarivelo, Caroline Turcotte, Étienne Doré, Isabelle Dubuc, Cyril Martin, Olivier Flamand, Youssef Amar, Amine Cheikh et al. · 2021 · The FASEB Journal
78. Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia
    Chiagozie Ifeoma Pickens, Catherine A. Gao, Michael J. Cuttica, Sean B. Smith, Lorenzo L. Pesce, Rogan A. Grant, Mengjia Kang, Luisa Morales‐Nebreda, Avni A. Bavishi, Jason M Arnold et al. · 2021 · American Journal of Respiratory and Critical Care Medicine
79. In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2
    Agnieszka M. Szemiel, Andres Merits, Richard J Orton, Oscar A. MacLean, Rute Maria Pinto, Arthur Wickenhagen, Gauthier Lieber, Matthew L. Turnbull, Sainan Wang, Wilhelm Furnon et al. · 2021 · PLoS Pathogens
80. Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative
    Blake Martin, Peter E. DeWitt, Seth Russell, Adit Anand, Katie R. Bradwell, Carolyn Bremer, Davera L Gabriel, Andrew T. Girvin, Janos Hajagos, Julie A. McMurry et al. · 2022 · JAMA Network Open
81. Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems
    Vijay Sagar Madamsetty, Reza Mohammadinejad, Ilona Uzielienè, Noushin Nabavi, Ali Dehshahri, Jomarien García-Couce, Shima Tavakol, Saeid Moghassemi, Arezoo Dadashzadeh, Pooyan Makvandi et al. · 2022 · ACS Biomaterials Science & Engineering
82. Ivermectin for preventing and treating COVID-19
    Maria Popp, Miriam Songa Stegemann, Maria-Inti Metzendorf, Susan Gould, Peter Kranke, Patrick Meybohm, Nicole Skoetz, Stephanie Weibel · 2021 · Cochrane Database of Systematic Reviews
83. Management of pneumonia in critically ill patients
    Catia Cillóniz, Antoní Torres, Michael S. Niederman · 2021 · BMJ
84. Factors leading to high morbidity and mortality of COVID ‐19 in patients with type 2 diabetes
    Aman Rajpal, Leili Rahimi, Faramarz Ismail‐Beigi · 2020 · Journal of Diabetes
85. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia
    Woon Hean Chong, Biplab Kumar Saha, Ananthakrishnan Ramani, Amit Chopra · 2021 · Infection
86. The Role of Glucocorticoids in Inflammatory Diseases
    Sybille D. Reichardt, Agathe Amouret, Chiara Muzzi, Sabine Vettorazzi, Jan Peter Tuckermann, Fred Lühder, Holger Michael Reichardt · 2021 · Cells
87. Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies
    Miquéias Lopes‐Pacheco, Pedro Leme Silva, Fernanda Ferreira Cruz, Denise Battaglini, Chiara Robba, Paolo P. Pelosi, Marcelo Marcos Morales, Celso Caruso Neves, Patrícia R. M. Rocco · 2021 · Frontiers in Physiology
88. Comparing machine learning algorithms for predicting ICU admission and mortality in COVID-19
    Sonu Subudhi, Ashish Verma, Ankit Bharat Patel, Corey Hardin, Melin Janardan Khandekar, Hang Lee, Dustin S. McEvoy, Triantafyllos Stylianopoulos, Lance L. Munn, Sayon Dutta et al. · 2021 · npj Digital Medicine
89. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up
    The Task Force for the management of COVID-19 of the European Society of Cardiology, Colin Baigent, Stephan Windecker, Daniele Andreini, Elena Arbelo, Emanuele Barbato, Antonio Luca Bartorelli, Andreas Baumbach, Elijah Raphael Behr, Sérgio Luis Berti et al. · 2021 · European Heart Journal
90. Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine
    Grigoris Gerotziafas, M. Catalano, Mary Paula Colgan, Zsolt Pécsvárady, Jean Claude Wautrecht, Bahare Fazeli, Dan-Mircea Olinic, Katalin Farkas, Ismaı̈l Elalamy, Anna Falanga et al. · 2020 · Thrombosis and Haemostasis
91. Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis
    Changcheng Shi, Limin Wang, Jian Ye, Zhi‐Chun Gu, Shuying Wang, Junbo Xia, Yaping Xie, Qingyu Li, Renjie Xu, Nengming Lin · 2021 · BMC Infectious Diseases
92. Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis—A Critical Review of Its Pathogenesis and Treatment
    Jeremy C. McMurray, Joseph W. May, Madeleine White Cunningham, Olcay Y. Jones · 2020 · Frontiers in Pediatrics
93. A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus
    KENNETH C. KALUNIAN, Richard Alan Furie, Eric Francis Morand, Ian N Bruce, Susan Manzi, Yoshiya Tanaka, Kevin L. Winthrop, Ihor Hupka, Lijin (Jinny) Zhang, Shanti Werther et al. · 2022 · Arthritis & Rheumatology
94. ESCMID COVID-19 living guidelines: drug treatment and clinical management
    Michele Bartoletti, Özlem Kurt Azap, Aleksandra M. Barac, Linda Bussini, Önder Ergönül, Robert Krause, José Ramón Paño‐Pardo, Nicholas R. Power, Marcella Sibani, Bálint Gergely Szabó et al. · 2021 · Clinical Microbiology and Infection
95. Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome
    Jiao Liu, Sheng Zhang, Xuan Dong, Zhongyi Li, Qianghong Xu, Huibin Feng, Jing Cai, Sisi Huang, Jun Guo, Lidi Zhang et al. · 2020 · Journal of Clinical Investigation
96. Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes
    Weijian Hang, Chen Chen, John M. Seubert, Dao Wen Wang · 2020 · Signal Transduction and Targeted Therapy
97. Mortality in patients admitted to intensive care with COVID‐19: an updated systematic review and meta‐analysis of observational studies
    R. A. Armstrong, Andrew D. Kane, Emira Kursumovic, Fiona C. Oglesby, T. M. Cook · 2021 · Anaesthesia
98. COVID-19 versus Non–COVID-19 Acute Respiratory Distress Syndrome: Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers, and Clinical Outcomes
    William Bain, Haopu Yang, Faraaz Ali Shah, Tomeka L. Suber, Callie M. Drohan, Nameer Al‐Yousif, Rebecca DeSensi, N. Bensen, Caitlin Schaefer, Brian R. Rosborough et al. · 2021 · Annals of the American Thoracic Society
99. Circadian Rhythms, Disease and Chronotherapy
    Yool Lee, Jeffrey M. Field, Amita Sehgal · 2021 · Journal of Biological Rhythms
100. Impact of COVID-19 on cancer care in India: a cohort study
     Ranganathan, Priya, Sengar, Manju, Chinnaswamy, Girish, Agrawal, Gaurav, Arumugham, Rajkumar, Bhatt, Rajiv, Bilimagga, Ramesh, Chakrabarti, Jayanta, Chandrasekharan, Arun, Chaturvedi, Harit Kumar et al. · 2021 · The Lancet Oncology